Exchange: NASDAQ·Updated 07:34 PM EDT
Latest Earnings Results: Q1 '26

Reported: May 14

Estimated EPS

-$0.22

Reported EPS

$2.82

Surprise

+1381.82%

Estimated Rev

$16.34M

Reported Rev

$16.04M

Surprise

-1.84%

$FBIO Q1 '26 Earnings Results & Recap Journey Medical Corporation's total revenues increased 21% year-over-year to $16M in Q1 2026, driven by Emrosi revenues of $6.3M. The net loss narrowed to $2.2M, or $(0.08) per share, for the quarter.

Generated by Stocktwits using AI and company-reported earnings data for Q1 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.20
--
--
N/A
Q1 '26
-$0.22
$2.82
1381.82%
BEAT
Q4 '25
$0.11
-$0.15
-236.36%
MISSED
Q3 '25
-$0.42
$0.11
126.19%
BEAT
Q2 '25
-$0.36
$0.45
225.00%
BEAT

Advertisement|Remove ads.